Corcept Therapeutics (HTD) Revenue

3 Followers

Corcept Therapeutics Revenue

Corcept Therapeutics had a revenue of 256.15M in the quarter ending Jun 30, 2026, with 55.33%. This bring the company's revenue in the last twelve months to 830.81M, Decreased 8.02%. In the fiscal year ending Dec 31, 2025, Corcept Therapeutics had annual revenue of 761.41M with 12.79% growth.

Revenue (ttm)

830.81M

Revenue Growth

8.36%

P/S Ratio

13.93

Revenue/Employee

€1,043,023

Employees

730

Market Cap

€10.60B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	761.41M	86.37M	+12.79%
Dec 31, 2024	675.04M	192.66M	+39.94%
Dec 31, 2023	482.38M	80.52M	+20.04%
Dec 31, 2022	401.86M	35.88M	+9.80%
Dec 31, 2021	365.98M	12.10M	+3.42%
Dec 31, 2020	353.87M	47.39M	+15.46%
Dec 31, 2019	306.49M	55.24M	+21.99%
Dec 31, 2018	251.25M	92.05M	+57.82%
Dec 31, 2017	159.20M	―	―